Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, EcoR1 Capital, LLC, holds the title of Director at ANAPTYSBIO, INC.
On 2026-11-17, the insider transacted 374,580 shares.The shares were transacted at a weighted average price of $45.98 per share, resulting in a total market-relevant value of $17.2M.
EcoR1 Capital, LLC (Director) bought $17.2M of $ANAB
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.